Conflicts of interest M.C., M.B. and L.W. were employed by Barrier Therapeutics at the time of the study. B.S. is currently employed by Barrier Therapeutics.
Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis
Article first published online: 21 OCT 2008
© 2008 The Authors. Journal Compilation © 2008 British Association of Dermatologists
British Journal of Dermatology
Volume 160, Issue 1, pages 26–36, January 2009
How to Cite
Pavez Loriè, E., Cools, M., Borgers, M., Wouters, L., Shroot, B., Hagforsen, E., Törmä, H. and Vahlquist, A. (2009), Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. British Journal of Dermatology, 160: 26–36. doi: 10.1111/j.1365-2133.2008.08895.x
Results from this study have previously been presented at the Annual Society for Investigative Dermatology Meeting, Chicago, IL, U.S.A., March 2006 and the FASEB Retinoid Meeting, Palm Springs, CA, U.S.A., June 2006.
- Issue published online: 15 DEC 2008
- Article first published online: 21 OCT 2008
- Accepted for publication 26 April 2008
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.